Unlike traditional weight loss medications that often target a single pathway, cagrilintide acts as a dual agonist, primarily affecting both the amylin receptor and, in some cases, the calcitonin receptor
Early responders who lost at least 15 percent of their body weight by week 24 went on to achieve an incredible 27.7 percent mean weight loss by week 72 (Source: STEP UP Trial, Dicker et al., ECO Abstract 2026)
Bariatric surgery consultations count
Hypotension (Low Blood Pressure) In rare cases, GHK-Cu may cause a slight drop in blood pressure, leading to mild dizziness or lightheadedness
GLP-1 Receptor Shared with Semaglutide and Tirzepatide GLP-1 receptor activation is associated with appetite regulation, delayed gastric emptying, and glucose-dependent insulin secretion
(2024) 48:S2749